{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:01:12Z","timestamp":1781812872227,"version":"3.54.5"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Acute graft-versus-host disease (aGVHD) with skin manifestations reminiscent of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) is associated with poor outcomes. However, optimal management strategies to enhance quality of life in SJS\/TEN-like aGVHD remain undefined. This study aims to investigate the management of complex infections and acute ocular injury in patients with SJS\/TEN-like aGVHD following allogeneic hematopoietic stem cell transplantation. We conducted a comprehensive analysis of the treatment course for a patient with SJS\/TEN-like aGVHD, complemented by a literature review on acute ocular complications and their management in aGVHD\u00a0patients. A patient diagnosed with grade IV skin aGVHD received effective treatment for multidrug-resistant <jats:italic>Stenotrophomonas maltophilia<\/jats:italic> using minocycline, aztreonam, and ceftazidime-avibactam. Combination therapy with liposomal amphotericin B and voriconazole was efficacious against mixed fungal infections. Immunological assessments indicated reduced lymphocyte counts and increased myeloid-derived suppressor cells, with elevated CD4<jats:sup>+<\/jats:sup> PD-1<jats:sup>+<\/jats:sup> exhausted and memory cells, reflecting a complex interplay of immune hyperactivity and\u00a0suppression. A literature review showed that although age, gender, and transplant circumstances were not associated with ocular symptoms, grade II+ cutaneous aGVHD emerged as a key risk factor for conjunctival involvement, characterized by\u00a0exudation and pseudomembrane formation. Topical glucocorticoids, tacrolimus and cyclosporine eye drops were effective, necessitating regular pseudomembrane removal. Evaluating drug susceptibility and immune status is vital for formulating precise therapies. Early recognition and management of ocular symptoms in SJS\/TEN-like aGVHD are essential to prevent irreversible damage.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1588297","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:10:44Z","timestamp":1750047044000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of infection and ocular complications in pediatric SJS\/TEN-like acute graft-versus-host disease: a clinical case study and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Huimin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lintao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5966\/sctm.2012-0115","article-title":"Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment","volume":"2","author":"Sung","year":"2012","journal-title":"Stem Cells Trans Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT\u2013NIH\u2013CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplantation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00128071-200607010-00003","article-title":"Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies","volume":"7","author":"Tan","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.02.073","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"90","author":"Wei","year":"2024","journal-title":"Part II diagnosis management. J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23537","article-title":"Results of detailed investigations into stevens-johnson syndrome with severe ocular complications","volume":"59","author":"Ueta","year":"2018","journal-title":"Invest Ophthalmol Visual science."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0158-0","article-title":"Stevens-johnson syndrome and toxic epidermal necrolysis: an update","volume":"16","author":"Dodiuk-Gad","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jaad.2022.10.035","article-title":"Acute graft-versus-host disease presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort study","volume":"88","author":"Hung","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.917782","article-title":"Diagnostic and therapeutic dilemma in Stevens-Johnson syndrome-like acute graft-versus-host disease after liver transplantation: A case report","volume":"13","author":"Hung","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1133381","article-title":"Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease","volume":"10","author":"Tappeiner","year":"2023","journal-title":"Front Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0167129","DOI":"10.1371\/journal.pone.0167129","article-title":"Conjunctival acute graft-versus-host disease in adult patients receiving allogeneic hematopoietic stem cell transplantation: A cohort study","volume":"11","author":"Liu","year":"2016","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.jaip.2020.09.048","article-title":"Detecting lesional granulysin levels for rapid diagnosis of cytotoxic T lymphocyte-mediated bullous skin disorders","volume":"9","author":"Chen","year":"2021","journal-title":"J Allergy Clin Immunol In practice."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.v184.1","article-title":"Diagnosis of mycoplasma etiology in Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"184","author":"Russell","year":"2021","journal-title":"Br J Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2022.100480","article-title":"Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions","volume":"47","author":"Nakkam","year":"2022","journal-title":"Drug Metab pharmacokinetics."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000153","article-title":"Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions","volume":"25","author":"Kongpan","year":"2015","journal-title":"Pharmacogenetics Genomics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.jid.2020.11.027","article-title":"Granulysin-based lymphocyte activation test for evaluating drug causality in antiepileptics-induced severe cutaneous adverse reactions","volume":"141","author":"Chu","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1182\/blood-2018-99-110405","article-title":"HLA-a*0101 expression correlates with increased risk of severe cutaneous acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"132","author":"Fonseca","year":"2018","journal-title":"Blood."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.10.008","article-title":"The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a systematic review and meta-analysis","volume":"28","author":"Chuleerarux","year":"2022","journal-title":"Clin Microbiol infection: Off Publ Eur Soc Clin Microbiol Infect Diseases."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.752037","article-title":"Stenotrophomonas maltophilia Infections in Pediatric Patients - Experience at a European Center for Pediatric Hematology and Oncology","volume":"11","author":"Z\u00f6llner","year":"2021","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000001919","article-title":"Treatment outcomes of stenotrophomonas maltophilia bacteremia in critically ill children: A multicenter experience","volume":"20","author":"Tokatly Latzer","year":"2019","journal-title":"Pediatr Crit Care medicine: J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Societies."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00777-17","article-title":"Avibactam restores the susceptibility of clinical isolates of stenotrophomonas maltophilia to aztreonam","volume":"61","author":"Mojica","year":"2017","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00010-19","article-title":"Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-\u03b2-lactamase-producing gram-negative bacteria","volume":"63","author":"Emeraud","year":"2019","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa439.1787","article-title":"Dual therapy with aztreonam & Ceftazidime\/avibactam against multi-drug resistant stenotrophomonas maltophilia on tricuspid valve endocarditis","volume":"7","author":"Alexander","year":"2020","journal-title":"Open Forum Infect Diseases."},{"key":"B25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3390\/antibiotics13060553","article-title":"Optimizing antibiotic therapy for stenotrophomonas maltophilia infections in critically ill patients: A pharmacokinetic\/pharmacodynamic approach","volume":"13","author":"Barrasa","year":"2024","journal-title":"Antibiotics (Basel Switzerland)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12901","article-title":"Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis","volume":"62","author":"Nucci","year":"2019","journal-title":"Mycoses"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001059","article-title":"Epidemiological aspects and characterization of the resistance profile of Fusarium spp. in patients with invasive fusariosis","volume":"68","author":"Rosa","year":"2019","journal-title":"J Med Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02456-15","article-title":"International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for fusarium species identified by molecular methods for the CLSI broth microdilution method","volume":"60","author":"Espinel-Ingroff","year":"2016","journal-title":"Antimicrobial Agents chemotherapy."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/cup.13397","article-title":"Disseminated trichosporonosis with atypical histologic findings in a patient with acute lymphocytic leukemia","volume":"46","author":"Galligan","year":"2019","journal-title":"J cutaneous pathology."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-019-00416-w","article-title":"Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp","volume":"185","author":"Ram\u00edrez","year":"2020","journal-title":"Mycopathologia."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01505-18","article-title":"Invasive infections due to trichosporon: species distribution, genotyping, and antifungal susceptibilities from a multicenter study in China","volume":"57","author":"Guo","year":"2019","journal-title":"J Clin Microbiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/jof7100848","article-title":"Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Puerta-Alcalde","year":"2021","journal-title":"J fungi (Basel Switzerland)."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"New Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020073","article-title":"Novel developments in the prophylaxis and treatment of acute GVHD","volume":"142","author":"Jamy","year":"2023","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1182\/blood-2021-144591","article-title":"A single-arm, open-label, pilot study of the JAK1 selective inhibitor itacitinib for the prophylaxis of graft-versus-host disease and cytokine release syndrome in T-cell replete haploidentical peripheral blood hematopoietic cell transplantation","volume":"138","author":"Abboud","year":"2021","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn121090-20240608-00214","article-title":"Chinese expert consensus on the diagnosis and treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation (2024)","volume":"45","year":"2024","journal-title":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01225-7","article-title":"Pharmacokinetics and pharmacodynamics of ruxolitinib: A review","volume":"62","author":"Appeldoorn","year":"2023","journal-title":"Clin pharmacokinetics."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"New Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1917635","article-title":"Ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease","volume":"382","author":"Zeiser","year":"2020","journal-title":"New Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13045-016-0281-2","article-title":"Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease","volume":"9","author":"Fransolet","year":"2016","journal-title":"J Hematol Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(96)90074-X","article-title":"Pseudomembranous conjunctivitis following bone marrow transplantation: immunopathological and ultrastructural study of one case","volume":"27","author":"Janin","year":"1996","journal-title":"Hum pathology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1056\/NEJMicm1701185","article-title":"Acute ocular graft-versus-host disease","volume":"377","author":"Braun","year":"2017","journal-title":"New Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6430953","article-title":"Manifestation of clinical categories of ocular graft-versus-host disease","volume":"2018","author":"Qiu","year":"2018","journal-title":"J ophthalmology."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002959","article-title":"Tear cytokines as biomarkers for acute ocular graft-versus-host disease","volume":"41","author":"Qiu","year":"2022","journal-title":"Cornea."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/BF02982052","article-title":"Ocular manifestation of acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation","volume":"75","author":"Saito","year":"2002","journal-title":"Int J hematology."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200205000-00024","article-title":"Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506)","volume":"21","author":"Ahmad","year":"2002","journal-title":"Cornea."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/ped.13280","article-title":"Ocular and nasal symptoms prior to acute skin graft-versus-host disease","volume":"59","author":"Fujihara","year":"2017","journal-title":"Pediatr international: Off J Japan Pediatr Society."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01564-2","article-title":"Ocular graft-versus-host disease and dry eye disease after pediatric hematopoietic stem cell transplantation - incidence and risk factors","volume":"57","author":"Jeppesen","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1452245","article-title":"Case report: Toxic epidermal necrolysis as a unique presentation of acute graft versus host disease in a pediatric patient","volume":"15","author":"Marlowe","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1588297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T04:10:55Z","timestamp":1750047055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1588297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2025.1588297"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1588297","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"article-number":"1588297"}}